This inventor holds 1 USPTO granted patent. Top assignee: Euglena Co., Ltd.. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: The Innovative Journey of Takumi Takeda
Introduction
Takumi Takeda, an inventive mind based in Kitakami, Japan, is recognized for his significant contributions in the field of biotechnology. With a passion for innovation, he has developed a patented enzyme that plays a crucial role in the decomposition of unique polysaccharides derived from various natural sources.
Latest Patents
Takumi Takeda holds one patent for his groundbreaking work on B-1,3-glucanase. This invention encompasses a polynucleotide, recombinant vector, and transformant, along with methods for producing B-1,3-glucanase and an enzyme preparation aimed at producing paramylon with reduced molecular weight. The patented β-1,3-glucanase exhibits remarkable hydrolyzing capabilities, specifically targeting the β-1,3-bond of β-1,3-glucan. Some of its notable properties include a decomposition activity ratio of 20% or higher, an optimum pH range of 3.7 to 7.0, and an optimum temperature range of 30 to 70°C.
Career Highlights
Currently, Takumi Takeda is employed at Euglena Co., Ltd., where he continues to push the boundaries of biotechnological research. His work is characterized by innovative problem-solving and a commitment to improving enzyme production processes. His unique approach and dedication are evident in the success of his patent, which showcases his expertise in enzyme chemistry.
Collaborations
In his endeavors, Takumi collaborates with talented professionals such as Kengo Suzuki and Ryo Arashida. Together, they contribute to the research and development practices within Euglena Co., Ltd., thereby amplifying the impact of their work in the biotechnology sector.
Conclusion
Takumi Takeda stands out as an influential inventor in the biotechnology field, exemplifying how innovation can lead to significant advancements. His patent for the B-1,3-glucanase enzyme not only highlights his scientific ingenuity but also his dedication to enhancing natural resource utilization. As he continues his work at Euglena Co., Ltd., the scientific community eagerly anticipates his future contributions to innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile